Literature DB >> 27793662

Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp).

Alessandra Oliva1, L Scorzolini2, D Castaldi2, F Gizzi2, M De Angelis2, M Storto3, A D'Abramo2, F Aloj3, M T Mascellino2, C M Mastroianni2, V Vullo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27793662     DOI： 10.1016/j.jinf.2016.10.002

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  14 in total

1.  Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies.

Authors:  D R Giacobbe; A E Maraolo; C Viscoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-21       Impact factor: 3.267

2.  Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae.

Authors:  M Souli; I Karaiskos; A Masgala; L Galani; E Barmpouti; H Giamarellou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-16       Impact factor: 3.267

Review 3.  Treatment Options for Carbapenem- Resistant Gram-Negative Infections.

Authors:  Moritz Fritzenwanker; Can Imirzalioglu; Susanne Herold; Florian M Wagenlehner; Klaus-Peter Zimmer; Trinad Chakraborty
Journal:  Dtsch Arztebl Int       Date:  2018-05-21       Impact factor: 5.594

4.  Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies.

Authors:  Suttikiat Changruenngam; Charin Modchang; Dominique J Bicout
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.996

Review 5.  When One Drug Is Not Enough: Context, Methodology, and Future Prospects in Antibacterial Synergy Testing.

Authors:  Thea Brennan-Krohn; James E Kirby
Journal:  Clin Lab Med       Date:  2019-06-12       Impact factor: 1.935

Review 6.  Treating infections caused by carbapenemase-producing Enterobacterales (CPE): a pragmatic approach to antimicrobial stewardship on behalf of the UKCPA Pharmacy Infection Network (PIN).

Authors:  Stephen Hughes; Mark Gilchrist; Katie Heard; Ryan Hamilton; Jacqueline Sneddon
Journal:  JAC Antimicrob Resist       Date:  2020-10-05

7.  Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London.

Authors:  Jonathan A Otter; Michel Doumith; Frances Davies; Siddharth Mookerjee; Eleonora Dyakova; Mark Gilchrist; Eimear T Brannigan; Kathleen Bamford; Tracey Galletly; Hugo Donaldson; David M Aanensen; Matthew J Ellington; Robert Hill; Jane F Turton; Katie L Hopkins; Neil Woodford; Alison Holmes
Journal:  Sci Rep       Date:  2017-10-05       Impact factor: 4.379

8.  Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.

Authors:  Gennaro De Pascale; Gennaro Martucci; Luca Montini; Giovanna Panarello; Salvatore Lucio Cutuli; Daniele Di Carlo; Valentina Di Gravio; Roberta Di Stefano; Guido Capitanio; Maria Sole Vallecoccia; Piera Polidori; Teresa Spanu; Antonio Arcadipane; Massimo Antonelli
Journal:  Crit Care       Date:  2017-07-05       Impact factor: 9.097

9.  Successful Treatment of Klebsiella pneumoniae Harboring a Klebsiella pneumoniae Carbapenemase Isolated from Lumbar Wound Infection and Blood in a Patient with Hardware Retention.

Authors:  Alan Bulbin; Carol Bono; Tena Philp; Noriel Mariano; Carl Urban
Journal:  Case Rep Infect Dis       Date:  2017-09-17

Review 10.  New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Roman Manetsch; George A O'Doherty; James E Kirby
Journal:  Transl Res       Date:  2020-03-02       Impact factor: 7.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.